Finally, assessment of serpinA1 isoforms through a CIEF immunoassay provided good diagnostic value in differentiating AD patients from controls and LBD patients, with maximal results in the discrimination between demented patients affected by either AD or LBD. This evidence concerns the gene SERPINA1 and Alzheimer disease.